{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "e4d28688",
   "metadata": {},
   "outputs": [],
   "source": [
    "#from fastapi import FastAPI, UploadFile, File, Form\n",
    "import os\n",
    "import json\n",
    "import promptManager\n",
    "import outputFormating\n",
    "import pandas as pd\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "0bb2ae86",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Selected product:  TOTAL30\n"
     ]
    }
   ],
   "source": [
    "\n",
    "#Get marketing material\n",
    "marketing_material = input(\"Enter marketing material: \") \n",
    "\n",
    "# Select product - as you add more products it would be better to start using IDs but we are using names for ease of reading here.\n",
    "product=None\n",
    "while product is None:\n",
    "    product_num=input(\"1: Clareon® Toric Intraocular Lens (IOL) or 2:  PRECISION7® Contact Lenses\")\n",
    "\n",
    "    if product_num==\"1\":\n",
    "        product=\"ClareonPanOptix\"\n",
    "\n",
    "    elif product_num==\"2\":\n",
    "        product=\"TOTAL30\"\n",
    "    else:\n",
    "        print(\"Invalid input, please enter 1 or 2.\")\n",
    "    \n",
    "    print(\"Selected product: \", product)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "9120105e",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Prompt built:  You are a compliance grader evaluating medical marketing content in the U.S.\n",
      "\n",
      "Your goal is to:\n",
      "1) Reward similarity with approved claims.\n",
      "2) Penalize conflicts with FDA + FTC requirements.\n",
      "3) Return structured JSON referencing policy IDs.\n",
      "\n",
      "---\n",
      "\n",
      "## Marketing Text\n",
      "best eye product ever\n",
      "\n",
      "---\n",
      "\n",
      "## Policy Groups\n",
      "\n",
      "Approved Claims (positive alignment)\n",
      "- (approved:0) TOTAL30® contact lenses that feel like nothing, even at day 30.\n",
      "- (approved:1) The first and only monthly replacement Water Gradient contact lenses.\n",
      "- (approved:2) TOTAL30® contact lenses feature a gradual transition in water content, from 55 % at the core to nearly 100 % water at the outermost surface.\n",
      "- (approved:3) Water Gradient Technology in TOTAL30 contact lenses lasts for a full 30 days.\n",
      "- (approved:4) CELLIGENT® Technology creates a dynamic lens surface that biomimics the corneal surface.\n",
      "- (approved:5) Helps resist the adherence of bacteria and lipids for a clean lens.\n",
      "- (approved:6) Water Gradient delivers superior softness and superior lubricity vs. leading reusable lenses.\n",
      "- (approved:7) Class 1 UV Blocking delivers the highest level of UV protection available in a monthly replacement lens.\n",
      "- (approved:8) The first and only monthly replacement Water Gradient toric contact lenses.\n",
      "- (approved:9) TOTAL30 delivers the only Water Gradient, reusable lens that is clinically shown to feel like nothing, even on day 30.\n",
      "\n",
      "\n",
      "FDA Policies\n",
      "- (fda:0) 21 CFR § 886.5925(a): A soft (hydrophilic) contact lens is a device intended to be worn directly against the cornea and adjacent limbal and scleral areas of the eye to correct vision conditions or act as a therapeutic bandage.\n",
      "- (fda:1) 21 CFR § 886.5925(b)(1)-(2): Classification—Class II if intended for daily wear only; Class III if intended for extended wear.\n",
      "- (fda:2) 21 CFR § 886.5925(c): As of May 28, 1976, a PMA under section 515 of the act is required before a device described in paragraph (b)(2) may be commercially distributed.\n",
      "- (fda:3) 21 CFR § 886.1(a): This part sets forth the classification of ophthalmic devices intended for human use that are in commercial distribution.\n",
      "- (fda:4) 21 CFR § 801.1(a): The label of a device in package form shall specify conspicuously the name and place of business of the manufacturer, packer, or distributor.\n",
      "- (fda:5) 21 CFR § 801.3: Definitions—includes, among others, Automatic identification and data capture (AIDC) and other UDI-related terms.\n",
      "- (fda:6) 21 CFR § 801.5: Adequate directions for use means directions under which the layman can use a device safely and for the purposes for which it is intended.\n",
      "- (fda:7) 21 CFR § 801.15(a): Required label information must have the prominence and conspicuousness required by section 502(c) of the act.\n",
      "- (fda:8) 21 CFR § 801.18(a): Dates on device labels must be presented as YYYY-MM-DD (e.g., 2014-01-02).\n",
      "- (fda:9) 21 CFR § 801.109(c)-(d): Prescription devices—labeling in or on the dispensing package shall bear information for use, including indications, hazards, contraindications, side effects, and precautions; any distributed labeling must contain adequate information for such use.\n",
      "- (fda:10) 21 CFR § 801.20(a)(1)-(2): The label of every medical device and every device package shall bear a unique device identifier (UDI) meeting this subpart and Part 830.\n",
      "- (fda:11) 21 CFR § 801.45(a): A device required to bear a UDI on its label must also bear a permanent UDI marking on the device itself if intended to be used more than once and reprocessed before each use.\n",
      "- (fda:12) 21 CFR Part 830 (e.g., § 830.3): Establishes UDI system definitions, including AIDC and other terms used for device identification.\n",
      "- (fda:13) 21 CFR § 830.310: GUDID data submission—labeler must provide specified identifying information for each version or model required to bear a UDI.\n",
      "- (fda:14) FDA UDI Compliance Dates: Labels and packages of Class II devices must bear a UDI; dates must follow § 801.18; data must be submitted to GUDID as specified.\n",
      "- (fda:15) 21 CFR § 807.81: When a premarket notification submission is required.\n",
      "- (fda:16) 21 CFR § 807.87: Information required in a premarket notification (510(k)) submission.\n",
      "- (fda:17) 21 CFR § 807.92: Content and format of a 510(k) summary.\n",
      "- (fda:18) 21 CFR § 807.97: Misbranding by reference to premarket notification.\n",
      "- (fda:19) 21 CFR § 803.50(a): Manufacturer reporting—must report to FDA no later than 30 calendar days after becoming aware of information suggesting a device may have caused or contributed to a death or serious injury, or has malfunctioned as specified.\n",
      "- (fda:20) 21 CFR § 803.18(a): User facilities, importers, and manufacturers must establish and maintain MDR event files.\n",
      "- (fda:21) 21 CFR Part 806 (§ 806.1): Manufacturers and importers must report certain device corrections and removals and maintain records of all corrections and removals.\n",
      "- (fda:22) 21 CFR § 800.10(a)(1): All preparations intended for ophthalmic use, including contact lens solutions, should be sterile.\n",
      "- (fda:23) 21 CFR § 800.12: Contact lens solutions and tablets; tamper-resistant packaging requirements.\n",
      "\n",
      "\n",
      "FTC Policies\n",
      "- (ftc:0) § 315.1: This part, which shall be called the “Contact Lens Rule,” implements the Fairness to Contact Lens Consumers Act, codified at 15 U.S.C. 7601–7610.\n",
      "- (ftc:1) § 315.2: “Business hours” means the prescriber’s regular hours of business; “Direct communication” means completed communication by telephone, facsimile, or electronic mail.\n",
      "- (ftc:2) § 315.2: “Contact lens prescription” means a prescription, issued in accordance with State and Federal law, that contains the patient’s name, the date of examination, issue date, lens power, material or manufacturer, base curve or appropriate designation, and diameter when appropriate, and the prescriber’s name, contact information, and signature.\n",
      "- (ftc:3) § 315.3(a)(1): When a prescriber completes a contact lens fitting, the prescriber, whether or not requested by the patient, shall provide to the patient a copy of the contact lens prescription.\n",
      "- (ftc:4) § 315.3(a)(2)-(3): The prescriber shall, as directed by any person designated to act on behalf of the patient, verify the contact lens prescription by electronic or other means; and upon request, provide any person designated to act on behalf of the patient with a copy within forty (40) business hours of receipt of the request.\n",
      "- (ftc:5) § 315.3(b): A prescriber may not require the purchase of contact lenses, require additional payment, or require a waiver as a condition of providing or verifying a prescription.\n",
      "- (ftc:6) § 315.3(c)(1): Upon completion of a fitting, the prescriber shall request that the patient confirm receipt of the prescription using one of the methods specified or retain evidence of delivery if a digital copy was provided.\n",
      "- (ftc:7) § 315.3(c)(3): A prescriber must maintain for a period of not less than three years a copy of the signed confirmation, a copy of the digital prescription, or documentation of delivery.\n",
      "- (ftc:8) § 315.4: A prescriber may require payment before releasing a prescription only if immediate payment is required for an examination that reveals no need for ophthalmic goods; proof of insurance constitutes payment.\n",
      "- (ftc:9) § 315.5(a): A seller may sell contact lenses only in accordance with a prescription presented by the patient or prescriber, or verified by direct communication.\n",
      "- (ftc:10) § 315.5(b): For verification, a seller shall provide the prescriber with the patient’s full name and address, lens specifications, quantity ordered, date of request, verification date/time, and a contact person for the seller.\n",
      "- (ftc:11) § 315.5(c)(3): Passive verification—prescription is verified if the prescriber fails to communicate with the seller within eight business hours after receiving the request.\n",
      "- (ftc:12) § 315.5(d): Automated telephone verification must identify the call as a verification request, deliver the information in a slow and deliberate manner, be audible and comprehensible, and allow repetition at the prescriber’s option.\n",
      "- (ftc:13) § 315.5(e)-(f): If informed a prescription is inaccurate, expired, or otherwise invalid, the seller shall not fill it; a seller may not alter a prescription.\n",
      "- (ftc:14) § 315.6(a): A contact lens prescription shall expire on the date specified by State law if one year or more after issue; otherwise, the prescription shall expire not less than one year after issue, unless a shorter period is medically justified and documented.\n",
      "- (ftc:15) § 315.7: No person may represent, by advertisement, sales presentation, or otherwise, that contact lenses may be obtained without a prescription.\n",
      "- (ftc:16) § 315.8: A prescriber may not require a patient to sign a waiver or release as a condition of verifying or releasing a prescription or as a condition of any eye examination.\n",
      "- (ftc:17) § 315.9: Any violation of this Rule shall be treated as a violation of a rule under section 18 of the FTC Act regarding unfair or deceptive acts or practices.\n",
      "- (ftc:18) § 255.1(a): Endorsements must reflect the honest opinions, findings, beliefs, or experience of the endorser, and may not convey any representation that would be deceptive or could not be substantiated.\n",
      "- (ftc:19) § 255.2(b): If the advertiser does not have substantiation that the endorser’s experience represents what consumers will generally achieve, the advertisement must clearly and conspicuously disclose the generally expected performance in the depicted circumstances.\n",
      "- (ftc:20) § 255.3(a): Expert endorsements must be supported by an actual exercise of expertise, examination or testing conducted by the expert, and must compare products only on the basis of such expertise.\n",
      "- (ftc:21) § 255.4: Organizational endorsements shall be reached by a process adequate to ensure that the endorsement fairly represents the collective judgment of the organization.\n",
      "- (ftc:22) § 255.5: When there exists a connection between the endorser and the seller that might materially affect the weight or credibility of the endorsement, such connection must be clearly and conspicuously disclosed.\n",
      "- (ftc:23) § 255.6: Endorsements directed to children are of special concern and will be evaluated from the perspective of children.\n",
      "- (ftc:24) 15 U.S.C. § 45(a)(1): Unfair methods of competition in or affecting commerce, and unfair or deceptive acts or practices in or affecting commerce, are hereby declared unlawful.\n",
      "- (ftc:25) 15 U.S.C. § 52(a): It shall be unlawful for any person, partnership, or corporation to disseminate, or cause to be disseminated, any false advertisement for the purpose of inducing, or which is likely to induce, directly or indirectly, the purchase of food, drugs, devices, services, or cosmetics.\n",
      "- (ftc:26) 15 U.S.C. § 55(a)(1): The term “false advertisement” means an advertisement, other than labeling, which is misleading in a material respect; in determining whether an advertisement is misleading, there shall be taken into account representations made or suggested and the extent to which the advertisement fails to reveal facts material in light of such representations.\n",
      "- (ftc:27) 15 U.S.C. § 7601: Availability of contact lens prescriptions to patients—prescribers shall provide to the patient a copy of the contact lens prescription upon completion of a contact lens fitting.\n",
      "- (ftc:28) 15 U.S.C. § 7603: Prescriber verification—sellers may dispense contact lenses only in accordance with a contact lens prescription that is presented or has been verified by the prescriber.\n",
      "- (ftc:29) 15 U.S.C. § 7605: Content of advertisements and other representations—prohibits representing that contact lenses may be obtained without a prescription.\n",
      "\n",
      "\n",
      "---\n",
      "\n",
      "## Scoring Rules\n",
      "\n",
      "### Approved Claims\n",
      "If text is similar in meaning to an approved claim → high score.\n",
      "- Very similar wording → 85–100\n",
      "- Same meaning (rephrased) → 70–85\n",
      "- Partial alignment → 50–70\n",
      "- Unrelated → 0–50\n",
      "\n",
      "### FDA / FTC Policies\n",
      "Must be followed.\n",
      "Conflicts → lower score.\n",
      "\n",
      "---\n",
      "\n",
      "## Output Rules\n",
      "- You must evaluate EVERY policy in ALL policy groups (Approved, FDA, FTC). No exceptions.\n",
      "- Produce exactly one evaluation object per policy.\n",
      "- If the policy is unrelated, still output it with a high grade (e.g., 80–100) and reason \"Unrelated; no conflict.\"\n",
      "- Include: policy_id, policy, type, grade, reason.\n",
      "- Higher scores = stronger compliance.\n",
      "- Return ONLY JSON in the required format.\n",
      "- Do NOT include any text outside the JSON structure.\n",
      "\n",
      "Return ONLY JSON, no commentary.\n",
      "\n",
      "### Output JSON format\n",
      "{\n",
      "  \"evaluations\": [\n",
      "    {\n",
      "        \"policy_id\": \"<approved:3 | fda:7 | ftc:5>\",\n",
      "        \"policy\": \"<policy text>\",\n",
      "      \"type\": \"<approved | fda | ftc>\",\n",
      "      \"grade\": <0-100>,\n",
      "      \"reason\": \"<brief justification>\"\n",
      "    }\n",
      "  ],\n",
      "  \"overall_summary\": \"<short summary>\"\n",
      "}\n"
     ]
    }
   ],
   "source": [
    "prompt=promptManager.buildPrompt(marketing_material, product)\n",
    "print(\"Prompt built: \", prompt)\n",
    "\n",
    "#Get response from LLM\n",
    "output=promptManager.getResponseFromLLM(prompt)\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "9b1de050",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Output from LLM:  {'evaluations': [{'policy_id': 'approved:0', 'policy': 'TOTAL30® contact lenses that feel like nothing, even at day\\u202f30.', 'type': 'approved', 'grade': 20, 'reason': \"Text 'best eye product ever' does not specifically mention TOTAL30 or contact lenses feeling like nothing.\"}, {'policy_id': 'approved:1', 'policy': 'The first and only monthly replacement Water Gradient contact lenses.', 'type': 'approved', 'grade': 10, 'reason': 'No mention of monthly replacement or Water Gradient contact lenses.'}, {'policy_id': 'approved:2', 'policy': 'TOTAL30® contact lenses feature a gradual transition in water content, from 55\\u202f% at the core to nearly 100\\u202f% water at the outermost surface.', 'type': 'approved', 'grade': 10, 'reason': 'No technical detail or water content claim present.'}, {'policy_id': 'approved:3', 'policy': 'Water Gradient Technology in TOTAL30 contact lenses lasts for a full 30 days.', 'type': 'approved', 'grade': 10, 'reason': 'No mention of Water Gradient Technology or duration.'}, {'policy_id': 'approved:4', 'policy': 'CELLIGENT® Technology creates a dynamic lens surface that biomimics the corneal surface.', 'type': 'approved', 'grade': 10, 'reason': 'No mention of CELLIGENT® Technology or biomimicry.'}, {'policy_id': 'approved:5', 'policy': 'Helps resist the adherence of bacteria and lipids for a clean lens.', 'type': 'approved', 'grade': 10, 'reason': 'No mention of bacteria or lipid resistance.'}, {'policy_id': 'approved:6', 'policy': 'Water Gradient delivers superior softness and superior lubricity vs. leading reusable lenses.', 'type': 'approved', 'grade': 10, 'reason': 'No mention of softness, lubricity, or comparison to other lenses.'}, {'policy_id': 'approved:7', 'policy': 'Class\\u202f1\\u202fUV Blocking delivers the highest level of UV protection available in a monthly replacement lens.', 'type': 'approved', 'grade': 10, 'reason': 'No mention of UV protection.'}, {'policy_id': 'approved:8', 'policy': 'The first and only monthly replacement Water Gradient toric contact lenses.', 'type': 'approved', 'grade': 10, 'reason': 'No mention of toric lenses or monthly replacement Water Gradient lenses.'}, {'policy_id': 'approved:9', 'policy': 'TOTAL30 delivers the only Water Gradient, reusable lens that is clinically shown to feel like nothing, even on day\\u202f30.', 'type': 'approved', 'grade': 20, 'reason': \"General phrase 'best eye product ever' is vague and does not directly align with 'clinically shown to feel like nothing'.\"}, {'policy_id': 'fda:0', 'policy': '21 CFR § 886.5925(a): A soft (hydrophilic) contact lens is a device intended to be worn directly against the cornea and adjacent limbal and scleral areas of the eye to correct vision conditions or act as a therapeutic bandage.', 'type': 'fda', 'grade': 90, 'reason': 'Unrelated; marketing text does not mention device definition or intended use.'}, {'policy_id': 'fda:1', 'policy': '21 CFR § 886.5925(b)(1)-(2): Classification—Class II if intended for daily wear only; Class III if intended for extended wear.', 'type': 'fda', 'grade': 90, 'reason': 'Unrelated; classification information not addressed in marketing text.'}, {'policy_id': 'fda:2', 'policy': '21 CFR § 886.5925(c): As of May 28, 1976, a PMA under section 515 of the act is required before a device described in paragraph (b)(2) may be commercially distributed.', 'type': 'fda', 'grade': 90, 'reason': 'Unrelated; no distribution or PMA claims.'}, {'policy_id': 'fda:3', 'policy': '21 CFR § 886.1(a): This part sets forth the classification of ophthalmic devices intended for human use that are in commercial distribution.', 'type': 'fda', 'grade': 90, 'reason': 'Unrelated; classification specifics not discussed.'}, {'policy_id': 'fda:4', 'policy': '21 CFR § 801.1(a): The label of a device in package form shall specify conspicuously the name and place of business of the manufacturer, packer, or distributor.', 'type': 'fda', 'grade': 90, 'reason': 'Unrelated; no labeling claims.'}, {'policy_id': 'fda:5', 'policy': '21 CFR § 801.3: Definitions—includes, among others, Automatic identification and data capture (AIDC) and other UDI-related terms.', 'type': 'fda', 'grade': 90, 'reason': 'Unrelated; definitions not relevant to marketing text.'}, {'policy_id': 'fda:6', 'policy': '21 CFR § 801.5: Adequate directions for use means directions under which the layman can use a device safely and for the purposes for which it is intended.', 'type': 'fda', 'grade': 90, 'reason': 'Unrelated; no directions for use provided in text.'}, {'policy_id': 'fda:7', 'policy': '21 CFR § 801.15(a): Required label information must have the prominence and conspicuousness required by section 502(c) of the act.', 'type': 'fda', 'grade': 90, 'reason': 'Unrelated; no label information in marketing text.'}, {'policy_id': 'fda:8', 'policy': '21 CFR § 801.18(a): Dates on device labels must be presented as YYYY-MM-DD (e.g., 2014-01-02).', 'type': 'fda', 'grade': 90, 'reason': 'Unrelated; no dates mentioned.'}, {'policy_id': 'fda:9', 'policy': '21 CFR § 801.109(c)-(d): Prescription devices—labeling in or on the dispensing package shall bear information for use, including indications, hazards, contraindications, side effects, and precautions; any distributed labeling must contain adequate information for such use.', 'type': 'fda', 'grade': 90, 'reason': 'Unrelated; no labeling or prescribed indications mentioned.'}, {'policy_id': 'fda:10', 'policy': '21 CFR § 801.20(a)(1)-(2): The label of every medical device and every device package shall bear a unique device identifier (UDI) meeting this subpart and Part 830.', 'type': 'fda', 'grade': 90, 'reason': 'Unrelated; no label or UDI information.'}, {'policy_id': 'fda:11', 'policy': '21 CFR § 801.45(a): A device required to bear a UDI on its label must also bear a permanent UDI marking on the device itself if intended to be used more than once and reprocessed before each use.', 'type': 'fda', 'grade': 90, 'reason': 'Unrelated; no packaging or device identifier claims.'}, {'policy_id': 'fda:12', 'policy': '21 CFR Part 830 (e.g., § 830.3): Establishes UDI system definitions, including AIDC and other terms used for device identification.', 'type': 'fda', 'grade': 90, 'reason': 'Unrelated; no device identification content.'}, {'policy_id': 'fda:13', 'policy': '21 CFR § 830.310: GUDID data submission—labeler must provide specified identifying information for each version or model required to bear a UDI.', 'type': 'fda', 'grade': 90, 'reason': 'Unrelated; no mention of labeling or data submission.'}, {'policy_id': 'fda:14', 'policy': 'FDA UDI Compliance Dates: Labels and packages of Class II devices must bear a UDI; dates must follow § 801.18; data must be submitted to GUDID as specified.', 'type': 'fda', 'grade': 90, 'reason': 'Unrelated; no compliance dates or label claims.'}, {'policy_id': 'fda:15', 'policy': '21 CFR § 807.81: When a premarket notification submission is required.', 'type': 'fda', 'grade': 90, 'reason': 'Unrelated; no mention of submissions or notifications.'}, {'policy_id': 'fda:16', 'policy': '21 CFR § 807.87: Information required in a premarket notification (510(k)) submission.', 'type': 'fda', 'grade': 90, 'reason': 'Unrelated; no submission content.'}, {'policy_id': 'fda:17', 'policy': '21 CFR § 807.92: Content and format of a 510(k) summary.', 'type': 'fda', 'grade': 90, 'reason': 'Unrelated; marketing text unrelated to submissions.'}, {'policy_id': 'fda:18', 'policy': '21 CFR § 807.97: Misbranding by reference to premarket notification.', 'type': 'fda', 'grade': 90, 'reason': 'Unrelated; no reference to premarket notification.'}, {'policy_id': 'fda:19', 'policy': '21 CFR § 803.50(a): Manufacturer reporting—must report to FDA no later than 30 calendar days after becoming aware of information suggesting a device may have caused or contributed to a death or serious injury, or has malfunctioned as specified.', 'type': 'fda', 'grade': 90, 'reason': 'Unrelated; no safety or adverse event information.'}, {'policy_id': 'fda:20', 'policy': '21 CFR § 803.18(a): User facilities, importers, and manufacturers must establish and maintain MDR event files.', 'type': 'fda', 'grade': 90, 'reason': 'Unrelated; no event files or MDR references.'}, {'policy_id': 'fda:21', 'policy': '21 CFR Part 806 (§ 806.1): Manufacturers and importers must report certain device corrections and removals and maintain records of all corrections and removals.', 'type': 'fda', 'grade': 90, 'reason': 'Unrelated; no corrections or removals information.'}, {'policy_id': 'fda:22', 'policy': '21 CFR § 800.10(a)(1): All preparations intended for ophthalmic use, including contact lens solutions, should be sterile.', 'type': 'fda', 'grade': 90, 'reason': 'Unrelated; no mention of solutions or sterility.'}, {'policy_id': 'fda:23', 'policy': '21 CFR § 800.12: Contact lens solutions and tablets; tamper-resistant packaging requirements.', 'type': 'fda', 'grade': 90, 'reason': 'Unrelated; no packaging or solution references.'}, {'policy_id': 'ftc:0', 'policy': '§ 315.1: This part, which shall be called the “Contact Lens Rule,” implements the Fairness to Contact Lens Consumers Act, codified at 15 U.S.C. 7601–7610.', 'type': 'ftc', 'grade': 90, 'reason': 'Unrelated; general rule reference.'}, {'policy_id': 'ftc:1', 'policy': '§ 315.2: “Business hours” means the prescriber’s regular hours of business; “Direct communication” means completed communication by telephone, facsimile, or electronic mail.', 'type': 'ftc', 'grade': 90, 'reason': 'Unrelated; definitions not relevant.'}, {'policy_id': 'ftc:2', 'policy': '§ 315.2: “Contact lens prescription” means a prescription, issued in accordance with State and Federal law, that contains the patient’s name, the date of examination, issue date, lens power, material or manufacturer, base curve or appropriate designation, and diameter when appropriate, and the prescriber’s name, contact information, and signature.', 'type': 'ftc', 'grade': 90, 'reason': 'Unrelated; no prescription details in text.'}, {'policy_id': 'ftc:3', 'policy': '§ 315.3(a)(1): When a prescriber completes a contact lens fitting, the prescriber, whether or not requested by the patient, shall provide to the patient a copy of the contact lens prescription.', 'type': 'ftc', 'grade': 90, 'reason': 'Unrelated; no fitting or prescription provision claims.'}, {'policy_id': 'ftc:4', 'policy': '§ 315.3(a)(2)-(3): The prescriber shall, as directed by any person designated to act on behalf of the patient, verify the contact lens prescription by electronic or other means; and upon request, provide any person designated to act on behalf of the patient with a copy within forty (40) business hours of receipt of the request.', 'type': 'ftc', 'grade': 90, 'reason': 'Unrelated; no prescription verification details.'}, {'policy_id': 'ftc:5', 'policy': '§ 315.3(b): A prescriber may not require the purchase of contact lenses, require additional payment, or require a waiver as a condition of providing or verifying a prescription.', 'type': 'ftc', 'grade': 90, 'reason': 'Unrelated; no conditions or requirements mentioned.'}, {'policy_id': 'ftc:6', 'policy': '§ 315.3(c)(1): Upon completion of a fitting, the prescriber shall request that the patient confirm receipt of the prescription using one of the methods specified or retain evidence of delivery if a digital copy was provided.', 'type': 'ftc', 'grade': 90, 'reason': 'Unrelated; no fitting or confirmation claims.'}, {'policy_id': 'ftc:7', 'policy': '§ 315.3(c)(3): A prescriber must maintain for a period of not less than three years a copy of the signed confirmation, a copy of the digital prescription, or documentation of delivery.', 'type': 'ftc', 'grade': 90, 'reason': 'Unrelated; no documentation claims.'}, {'policy_id': 'ftc:8', 'policy': '§ 315.4: A prescriber may require payment before releasing a prescription only if immediate payment is required for an examination that reveals no need for ophthalmic goods; proof of insurance constitutes payment.', 'type': 'ftc', 'grade': 90, 'reason': 'Unrelated; no payment or prescription release claims.'}, {'policy_id': 'ftc:9', 'policy': '§ 315.5(a): A seller may sell contact lenses only in accordance with a prescription presented by the patient or prescriber, or verified by direct communication.', 'type': 'ftc', 'grade': 90, 'reason': 'Unrelated; no sales or prescription claims.'}, {'policy_id': 'ftc:10', 'policy': '§ 315.5(b): For verification, a seller shall provide the prescriber with the patient’s full name and address, lens specifications, quantity ordered, date of request, verification date/time, and a contact person for the seller.', 'type': 'ftc', 'grade': 90, 'reason': 'Unrelated; no verification process described.'}, {'policy_id': 'ftc:11', 'policy': '§ 315.5(c)(3): Passive verification—prescription is verified if the prescriber fails to communicate with the seller within eight business hours after receiving the request.', 'type': 'ftc', 'grade': 90, 'reason': 'Unrelated; no verification details.'}, {'policy_id': 'ftc:12', 'policy': '§ 315.5(d): Automated telephone verification must identify the call as a verification request, deliver the information in a slow and deliberate manner, be audible and comprehensible, and allow repetition at the prescriber’s option.', 'type': 'ftc', 'grade': 90, 'reason': 'Unrelated; no verification or call details.'}, {'policy_id': 'ftc:13', 'policy': '§ 315.5(e)-(f): If informed a prescription is inaccurate, expired, or otherwise invalid, the seller shall not fill it; a seller may not alter a prescription.', 'type': 'ftc', 'grade': 90, 'reason': 'Unrelated; no accuracy or filling claims.'}, {'policy_id': 'ftc:14', 'policy': '§ 315.6(a): A contact lens prescription shall expire on the date specified by State law if one year or more after issue; otherwise, the prescription shall expire not less than one year after issue, unless a shorter period is medically justified and documented.', 'type': 'ftc', 'grade': 90, 'reason': 'Unrelated; no prescription expiration mentioned.'}, {'policy_id': 'ftc:15', 'policy': '§ 315.7: No person may represent, by advertisement, sales presentation, or otherwise, that contact lenses may be obtained without a prescription.', 'type': 'ftc', 'grade': 100, 'reason': 'Compliant; does not claim lenses obtainable without prescription.'}, {'policy_id': 'ftc:16', 'policy': '§ 315.8: A prescriber may not require a patient to sign a waiver or release as a condition of verifying or releasing a prescription or as a condition of any eye examination.', 'type': 'ftc', 'grade': 90, 'reason': 'Unrelated; no waiver or release requirements mentioned.'}, {'policy_id': 'ftc:17', 'policy': '§ 315.9: Any violation of this Rule shall be treated as a violation of a rule under section 18 of the FTC Act regarding unfair or deceptive acts or practices.', 'type': 'ftc', 'grade': 100, 'reason': 'No violation present.'}, {'policy_id': 'ftc:18', 'policy': '§ 255.1(a): Endorsements must reflect the honest opinions, findings, beliefs, or experience of the endorser, and may not convey any representation that would be deceptive or could not be substantiated.', 'type': 'ftc', 'grade': 50, 'reason': \"Vague superlative 'best eye product ever' could be unsubstantiated.\"}, {'policy_id': 'ftc:19', 'policy': '§ 255.2(b): If the advertiser does not have substantiation that the endorser’s experience represents what consumers will generally achieve, the advertisement must clearly and conspicuously disclose the generally expected performance in the depicted circumstances.', 'type': 'ftc', 'grade': 50, 'reason': \"No substantiation or expected performance disclosure for 'best' claim.\"}, {'policy_id': 'ftc:20', 'policy': '§ 255.3(a): Expert endorsements must be supported by an actual exercise of expertise, examination or testing conducted by the expert, and must compare products only on the basis of such expertise.', 'type': 'ftc', 'grade': 90, 'reason': 'Unrelated; no expert endorsement present.'}, {'policy_id': 'ftc:21', 'policy': '§ 255.4: Organizational endorsements shall be reached by a process adequate to ensure that the endorsement fairly represents the collective judgment of the organization.', 'type': 'ftc', 'grade': 90, 'reason': 'Unrelated; no organizational endorsement.'}, {'policy_id': 'ftc:22', 'policy': '§ 255.5: When there exists a connection between the endorser and the seller that might materially affect the weight or credibility of the endorsement, such connection must be clearly and conspicuously disclosed.', 'type': 'ftc', 'grade': 90, 'reason': 'Unrelated; no endorser or seller connection mentioned.'}, {'policy_id': 'ftc:23', 'policy': '§ 255.6: Endorsements directed to children are of special concern and will be evaluated from the perspective of children.', 'type': 'ftc', 'grade': 90, 'reason': 'Unrelated; no target audience identified as children.'}, {'policy_id': 'ftc:24', 'policy': '15 U.S.C. § 45(a)(1): Unfair methods of competition in or affecting commerce, and unfair or deceptive acts or practices in or affecting commerce, are hereby declared unlawful.', 'type': 'ftc', 'grade': 60, 'reason': \"Marketing text may be considered potentially deceptive due to vague 'best' claim lacking substantiation.\"}, {'policy_id': 'ftc:25', 'policy': '15 U.S.C. § 52(a): It shall be unlawful for any person, partnership, or corporation to disseminate, or cause to be disseminated, any false advertisement for the purpose of inducing, or which is likely to induce, directly or indirectly, the purchase of food, drugs, devices, services, or cosmetics.', 'type': 'ftc', 'grade': 60, 'reason': \"Claim 'best eye product ever' is unverifiable and could mislead consumers.\"}, {'policy_id': 'ftc:26', 'policy': '15 U.S.C. § 55(a)(1): The term “false advertisement” means an advertisement, other than labeling, which is misleading in a material respect; in determining whether an advertisement is misleading, there shall be taken into account representations made or suggested and the extent to which the advertisement fails to reveal facts material in light of such representations.', 'type': 'ftc', 'grade': 60, 'reason': 'Marketing text might be misleading due to a superlative that cannot be substantiated.'}, {'policy_id': 'ftc:27', 'policy': '15 U.S.C. § 7601: Availability of contact lens prescriptions to patients—prescribers shall provide to the patient a copy of the contact lens prescription upon completion of a contact lens fitting.', 'type': 'ftc', 'grade': 90, 'reason': 'Unrelated; no mention of prescription availability.'}, {'policy_id': 'ftc:28', 'policy': '15 U.S.C. § 7603: Prescriber verification—sellers may dispense contact lenses only in accordance with a contact lens prescription that is presented or has been verified by the prescriber.', 'type': 'ftc', 'grade': 90, 'reason': 'Unrelated; no reference to dispensing or prescription verification.'}, {'policy_id': 'ftc:29', 'policy': '15 U.S.C. § 7605: Content of advertisements and other representations—prohibits representing that contact lenses may be obtained without a prescription.', 'type': 'ftc', 'grade': 100, 'reason': 'Compliant; marketing text does not imply lenses can be obtained without a prescription.'}], 'overall_summary': \"The marketing text 'best eye product ever' is vague and does not align with any approved claims. While it does not violate FDA or FTC requirements regarding prescription or labeling, the unsubstantiated superlative can be potentially misleading and lacks the necessary evidence, resulting in moderate risk under FTC advertising substantiation rules.\"}\n"
     ]
    }
   ],
   "source": [
    "print(\"Output from LLM: \", output)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "183a98cb",
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "df = pd.DataFrame(output['evaluations'])\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "e20ae91d",
   "metadata": {},
   "outputs": [],
   "source": [
    "df.head(60)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "b019afe6",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Approved Score:  20\n",
      "FDA Score:  90.0\n",
      "FTC Score:  68.66666666666666\n"
     ]
    }
   ],
   "source": [
    "#get catagory scores\n",
    "approved_scores = df[df['type'] == 'approved']['grade']\n",
    "fda_scores = df[df['type'] == 'fda']['grade']\n",
    "ftc_scores = df[df['type'] == 'ftc']['grade']\n",
    "\n",
    "approved_score = approved_scores.max() if not approved_scores.empty else None\n",
    "\n",
    "def compute_category_score(df, category, threshold=70):\n",
    "    scores = df[df['type'] == category]['grade']\n",
    "\n",
    "    if scores.empty:\n",
    "        return 0\n",
    "    \n",
    "    base = scores.mean()\n",
    "    non_compliant_ratio = (scores < threshold).mean()\n",
    "    penalty = non_compliant_ratio * 100\n",
    "    \n",
    "    final = base - penalty\n",
    "    return max(0, min(100, final))  # clamp\n",
    "\n",
    "fda_score = compute_category_score(df, \"fda\")\n",
    "ftc_score = compute_category_score(df, \"ftc\")\n",
    "\n",
    "print(\"Approved Score: \", approved_score)\n",
    "print(\"FDA Score: \", fda_score)\n",
    "print(\"FTC Score: \", ftc_score)\n",
    "\n"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": ".venv",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.13.3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
